This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Hameln Pharma Gmbh, Hameln Pharma Plus Gmbh. Active years: 2016-2020.
Location History:
- Modra, SK (2016)
- Pezinok, SK (2020)
Company Filing History:
Years Active: 2016-2020
Title: Janka Králová: Innovator in Pharmaceutical Chemistry
Introduction
Janka Králová is a prominent inventor based in Pezinok, Slovakia. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of intermediates for drug synthesis. With a total of 2 patents, her work has garnered attention for its innovative approaches and practical applications.
Latest Patents
One of her latest patents involves the creation of intermediates for the preparation of remifentanil hydrochloride. This invention presents a new intermediate for synthesizing 1-substituted-4-[phenyl(propanoyl)amino]piperidine-4-carbonitrile derivatives. The method outlined in this patent offers a more efficient process, yielding products with higher purity compared to previous methods. Another notable patent pertains to the production of zinc trisodium pentetic acid (Zn-DTPA), which introduces new crystalline forms of this important salt.
Career Highlights
Throughout her career, Janka has worked with reputable companies such as Hameln Pharma GmbH and Hameln Pharma Plus GmbH. Her experience in these organizations has allowed her to refine her skills and contribute to various innovative projects in the pharmaceutical industry.
Collaborations
Janka has collaborated with several professionals in her field, including Pavol Valachovic and Ľubos Slízik. These partnerships have facilitated the exchange of ideas and have led to advancements in her research and inventions.
Conclusion
Janka Králová stands out as a talented inventor whose work in pharmaceutical chemistry has the potential to impact drug development significantly. Her innovative patents and collaborations reflect her dedication to advancing the field.